IDEXX Laboratories Inc (IDXX) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally.

Total Assets Chart for IDEXX Laboratories Inc

IDEXX Laboratories Inc (IDXX) total assets for FY2025 were USD 3.4B, a 1.7% change from FY2024. IDEXX Laboratories Inc's total assets grew from USD 38.1M in 1991 to USD 3.4B in 2025 (8694.6% over 34 years). Total assets compound annual growth rate: 5-year CAGR of 7.9%, 10-year CAGR of 8.6%, 20-year CAGR of 10.1%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$46.54B
Implied Share Price
$590.00
Enterprise Value
$47.30B
Revenue (TTM)
$4.55B
EBITDA
$1.62B
Profit Margin
25.03%
Trailing P/E
41.14
Forward P/E
39.84
Price/Book (MRQ)
29.81
Price/Sales (TTM)
10.21
EV/EBITDA
30.37
EV/Revenue
10.64
Dividend Yield
—
Book Value
$19.64
Free Cash Flow (FY2025)
$1.05B
Free Cash Flow Yield
2.26%

Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.